Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats?

Metabolism: Clinical and Experimental

Volumn 51, Issue 1, 2002, Pages 38-43

  Sunmin, Park ^a   Soo, Bong Choi ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; FLUOXETINE; GLUCOSE; GLYCOGEN; INSULIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; DIET RESTRICTION; DRUG EFFECT; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PANCREAS RESECTION; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE; WAKEFULNESS; WEIGHT REDUCTION;

EID: 0036146359     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.26712     Document Type: Article

References (34)

1. Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: A balanced overview
2. Role of 5-hydroxytryptamine in the regulation of brain neuropeptides in normal and diabetic rat
3. Inhibition of serotonin uptake
4. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats
5. Fluoxetine side-effects mimicking hypoglycemia
6. A study of fluoxetine in obese elderly patients with type 2 diabetes
7. Fluoxetine therapy in obese diabetic and glucose intolerant patients
8. Changes in energy during treatment of depression: An analysis of fluoxetine in double-blind, placebo-controlled trials
9. Fluoxetine improves insulin sensitivity in obese patients with non-insulin-dependent diabetes mellitus independently of weight loss
10. Usefulness of fluoxetine in obese non-insulin-dependent diabetics: A multicenter study
11. Long-term effects of fluoxetine on glycemic control in obese patients with non-insulin-dependent diabetes mellitus or glucose intolerance: Influence on muscle glycogen synthase and insulin receptor kinase activity
12. Fluoxetine in the treatment of obese type 2 diabetic patients
13. Mechanism of impaired glucose-potentiated insulin-secretion in diabetic 90 percent pancreatectomy rats - Study using glucagon-like peptide-1(7-37)
14. Specific surgical operation
15. Multiple metabolic effects of CGRP in conscious rats: Role of glycogen synthase and phosphorylase
16. Immunoassay of insulin: Two antibody system. Plasma insulin levels in normal, subdiabetic and diabetic rats
17. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
18. A simple method for measuring glucose utilization of insulin-sensitive tissues by using the brain reference
19. Short-term effects of leptin on hepatic gluconeogenesis and in vivo insulin action
20. Effect of glucose and insulin on triacylglycerol metabolism in isolated normal and diabetic skeletal muscle
21. Preclinical pharmacology of fluoxetine, a serotonergic drug for weight loss
22. A randomized double-blind clinical trial of fluoxetine in obese diabetics
23. Effects of insulin on local cerebral glucose utilization in the rat
24. Local cerebral glucose utilization in controlled graded levels of hyperglycemia in the conscious rat
25. Hyperinsulinemia suppresses glucose utilization in specific brain regions: In vivo studies using the euglycemic clamp in the rat
26. Mental stress increases glucose uptake during hyperinsulinemia: Associations with sympathetic and cardiovascular responsiveness
27. Neurological changes induced by stress in streptozotocin diabetic rats
28. Local cerebral metabolic effects of the novel cocaine analog, WF-31: Comparison to fluoxetine
29. The effects of cocaine on cerebral metabolic function in periweanling rats: The roles of serotonergic and dopaminergic uptake blockade
30. The anatomy of neuropeptide Y containing neurons in the rat brain
31. Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior
32. Neuronal localization of neuropeptide Y gene expression in rat brain
33. Dopaminergic and serotoninergic anorectics differentially antagonize insulin- and 2-DG-induced hyperphagia